iBio Inc. (NYSE AMERICAN: IBIO)
$2.12
-0.0300 ( -1.40% ) 16.9K
iBio Inc is a part of the healthcare sector. Its main business is commercialized technologies and product candidates and manufacturing services to clients and collaborators. Its main area of business is plant-based protein expression technologies for vaccines and therapeutic proteins and developing and commercializing select biopharmaceutical product candidates. Its products are used to combat various areas such as fibrotic diseases, cancers, and infectious diseases. The company operates in two segments: Biopharmaceuticals and Bioprocessing activities, conducted within iBio, Inc. and CDMO segment, conducted within iBio CDMO.
Market Data
Open
$2.12
Previous close
$2.15
Volume
16.9K
Market cap
$18.20M
Day range
$2.11 - $2.27
52 week range
$1.02 - $15.99
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
10-q | Quarterly Reports | 101 | Nov 14, 2023 |
4 | Insider transactions | 1 | Nov 03, 2023 |
def | Proxies and info statements | 7 | Oct 26, 2023 |
ars | Annual reports | 1 | Oct 26, 2023 |
pre | Proxies and info statements | 5 | Oct 16, 2023 |
8-k | 8K-related | 15 | Oct 10, 2023 |
4 | Insider transactions | 1 | Oct 05, 2023 |
4 | Insider transactions | 1 | Oct 03, 2023 |
8-k | 8K-related | 68 | Oct 02, 2023 |
8-k | 8K-related | 14 | Sep 27, 2023 |